SCHEMBL514082

SCHEMBL514082

FC[C]=S

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL513946 0.67
SCHEMBL5178909 0.59
SCHEMBL2016934 0.59
SCHEMBL721366 0.59
SCHEMBL465037 0.59
SCHEMBL16026432 0.56
SCHEMBL123253 0.56
SCHEMBL9525666 0.56
SCHEMBL15406223 0.56
SCHEMBL715493 0.56

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3151836-A2 COMPOSITION COMPRISING CYCLODEXTRIN AND BUDESONIDE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF PULMONARY INFLAMMATIONS Université de Liège (BE) 2017-04-12 EP claimed
CN-106413759-A Composition comprising cyclodextrin and budesonide derivatives for the treatment and prevention of pulmonary inflammation 列日大学 2017-02-15 CN claimed
US-20160051568-A1 CYCLODEXTRIN AND BUDESONIDE DERIVATIVE COMPOSITIONS AND METHODS MAES PAUL (BE) 2016-02-25 US claimed
EP-2923702-A1 Composition of cyclodextrin with budesonide derivatives for treatment and prevention of pulmonary inflammatory disease Universite De Liege (BE) 2015-09-30 EP claimed
WO-2023210623-A1 HALOALKYL SULFONE ANILIDE COMPOUND AND HERBICIDE CONTAINING SAME 株式会社エス・ディー・エス バイオテック 2023-11-02 WO disclosed
US-11576914-B2 Drug for treating or preventing disorder caused by TGF-β signaling, and application thereof THE DOSHISHA (JP) 2023-02-14 US disclosed
EP-4122469-A1 COMPOSITION COMPRISING CYCLODEXTRIN AND BUDESONIDE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF PULMONARY INFLAMMATIONS Maes, Paul (BE) 2023-01-25 EP disclosed
CN-106413759-B Composition comprising cyclodextrin and budesonide derivatives for the treatment and prevention of pulmonary inflammation 列日大学 2022-02-22 CN disclosed
CN-113144215-A Composition comprising cyclodextrin and budesonide derivatives for the treatment and prevention of pulmonary inflammation 列日大学 2021-07-23 CN disclosed
US-20210008067-A1 DRUG FOR TREATING OR PREVENTING DISORDER CAUSED BY TGF-ß SIGNALLING, AND APPLICATION THEREOF THE DOSHISHA (JP) 2021-01-14 US disclosed
EP-3659626-A1 DRUG FOR TREATING OR PREVENTING DISORDER CAUSED BY TGF- SIGNALLING, AND APPLICATION THEREOF The Doshisha (JP) 2020-06-03 EP disclosed
US-9993487-B2 Cyclodextrin and budesonide derivative compositions and methods UNIV LIEGE (BE) 2018-06-12 US disclosed
EP-2036905-A1 PYRIDYLISOXAZOLE DERIVATIVE ASKA Pharmaceutical Co., Ltd. (JP) 2009-03-18 EP disclosed
WO-2008015250-A1 PYRIMIDINE COMPOUNDS FOR COMBATING PATHOGENIC FUNGI AND CANCER BASF SE (DE) 2008-02-07 WO disclosed
US-20020156285-A1 Novel herbicides KUNZ WALTER (CH) 2002-10-24 US disclosed
US-6369002-B1 HETERO IS PYRIMIDINE OR PYRIDAZINE; 1-(3-FLUORO-5-CHLORO PYRIDIN-2-YL)-3-METHYL-4-TRIFLUOROMETHYLPYRIMIDIN-2,6-DIONE SYNGENTA CROP PROPERTIES, INC. 2002-04-09 US disclosed
US-6339046-B1 FOR CONTROLLING WEEDS SYNGENTA INVESTMENT CORPORATION 2002-01-15 US disclosed
EP-1076656-A2 N-HETEROARYL-SUBSTITUTED PYRIDINE DERIVATIVES AND THEIR USE AS HERBICIDES Novartis AG (CH) 2001-02-21 EP disclosed
WO-1999055693-A2 N-HETEROARYL-SUBSTITUTED PYRIDINE DERIVATIVES AND THEIR USE AS HERBICIDES NOVARTIS AG (CH) 1999-11-04 WO disclosed
EP-0839808-A1 Pyrazole derivatives, processes for their preparation, and their use as herbicides Novartis AG (CH) 1998-05-06 EP disclosed